You are in the accessibility menu

Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLongatto Filho, Adhemar-
dc.contributor.authorBisi, Hélio-
dc.contributor.authorAlves, Venâncio Avancini Ferreira-
dc.contributor.authorKanamura, Cristina Takami-
dc.contributor.authorOyafuso, Marina Suheko-
dc.contributor.authorBortolan, Jeni-
dc.contributor.authorLombardo, Valéria-
dc.identifier.citationActa Cytologica, v. 41, n. 4, p. 961-971, 1997.-
dc.description.abstractOBJECTIVE: To investigate the usefulness of assessing the immunoreactivity of cytokeratins 7 (CK7) and 20 (CK20) as well as several cytomorphologic parameters in effusions with metastatic adenocarcinomas in the search for the primary site of the tumor. STUDY DESIGN: From the files of the Pathology Department, A. C. Camargo Hospital, we studied cytologic smears from 73 metastatic adenocarcinomas originally from the breast, 63 from the ovary, 40 from the lung and 32 from the stomach, looking for morphologic parameters that could have discriminant potential in suggesting the primary site in a routine situation, including intranuclear inclusions, prominent nucleoli, mitosis, signet-ring cells, psammoma bodies, nuclear crease, binucleation and multinucleation, papillary features, acinar profile (including ball cells) and single cells. Immunoreactions were performed with monoclonal antibodies to CK7 (OV-TL 12/30 and CK20 (Ks 20.8) and included morphologic analysis. Both analyses were studied in a blind fashion regarding the primary site of the tumors. RESULTS: Positivity ratios for breast, ovary, stomach and lung cases were 67.6%, 63.5%, 29.7% and 45.5%, respectively, for CK7 and 17.2%, 15.8%, 13.5% and 32.2%, respectively, for CK20. Discriminant analysis of morphologic and immunocytochemical parameters had an error rate of 42.9% in recognizing the primary site and a Wilk's lambda of .7290. CONCLUSION: The more efficient parameter with discriminant function was the papillary appearance showed by CK7, which should be used in further studies with a similar scope. The set of parameters used in this study were insufficient to discriminate the primary site of female adenocarcinomas in effusions with significant accuracy.en
dc.subjectcytokeratin 20-
dc.subjectcytokeratin 7-
dc.subjectunclassified drug-
dc.subjectbreast carcinoma-
dc.subjectcancer cytodiagnosis-
dc.subjectcancer localization-
dc.subjectclinical article-
dc.subjectintermediate filament-
dc.subjectlung carcinoma-
dc.subjectovary carcinoma-
dc.subjectpriority journal-
dc.subjectstomach carcinoma-
dc.subjectBreast Neoplasms-
dc.subjectIntermediate Filament Proteins-
dc.subjectLung Neoplasms-
dc.subjectNeoplasms, Unknown Primary-
dc.subjectOvarian Neoplasms-
dc.subjectSerous Membrane-
dc.subjectStomach Neoplasms-
dc.subjectTumor Markers, Biological-
dc.titleAdenocarcinoma in females detected in serous effusions: Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20en
dc.contributor.institutionInstituto Adolfo Lutz (IAL)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionA. C. Camargo Cancer Center-
dc.contributor.institutionOncocentro Foundation-
dc.description.affiliationPathology Division Adolfo Lutz Institute, São Paulo-
dc.description.affiliationPathology Department São Paulo State University Medical School, São Paulo-
dc.description.affiliationSurgical Pathology Department A. C. Camargo Hospital, São Paulo-
dc.description.affiliationDiv. of Epidemiol. and Biostatistics Oncocentro Foundation, São Paulo-
dc.description.affiliationSetor de Citologia Oncotica Divisão de Patologia Instituto Adolfo Lutz, Av. Dr. Arnaldo, 355, São Paulo, SP-
dc.description.affiliationUnespPathology Department São Paulo State University Medical School, São Paulo-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofActa Cytologica-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.